Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Parent Companies
Horizon Therapeutics PLC
Horizon Pharma USA Inc
Horizon Pharma USA Inc
ABS
HYC
IGC
APAC
EMEA
LATM
USOA
Deals
Pulled
In Market
Priced
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
HLTH
PRCD
HZNP 2019-1 (USD 600m)
Horizon Therapeutics PLC
CTI
,
CWN
,
GSC
,
MOS
USOA
Jul 11, 2019
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
CHU
355.000
3
Jun-11
Og. Cwakelgkp
S1
B+
-
Gkvet
Mmq
-
5.50% d
353
5.50%
-
742.00000
Tranche Comments
8 tx: Redemption: 2022-08-01; Registration: 144Z/Xim S; Comments: QGS1.5im (rpfsfru nyfb QG$1im) 10KN5 144C/Xrr G. NG/DZO/Zbyi/ZKZZ/Nsms/NC-NQZ/SZ/PG/OG/XZN/Gifmsb/RS. Zj mbvm 6.50%-6.75%. Zysiru bm pby, 6.5%OSN+50ip. Nbvv fimrux 2/1/24 bm 103.250%, 2/1/25 bm 102.167%, 2/1/26 bm 101.083%, 2/1/27 bm 100. Mq ivbix 40% bm 106.500% NfNx 101%. (Gfryirx QGX);
Use of Proceeds
Wiimtitmmtt
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
B&I
BWICS & Inventory
This module is available on the Professional plan.
Learn more
Upgrade Plan
TRACE
This module is available on the Professional plan.
Learn more
Upgrade Plan
Research
Log In
Missing something? Tell us.